Adjuvants for specific immunotherapy past, present, future
Drachenberg, K.J.
Arbeiten aus dem Paul-Ehrlich-Institut Zu Frankfurt A.M 93 275-279; Discussion: 280-281
1999
ISSN/ISBN: 0936-8671 PMID: 11487886 Document Number: 504670
Document emailed within 1 workday
Related Documents
Johnstone, D.E. 1981: Immunotherapy in children: past, present, and future. (Part I) Annals of Allergy 46(1): 1-7Watanabe, Y.; Shimizu, J.; Oda, M.; Yoshida, M.; Watanabe, S.; Iwa, T. 1991: Clinical significance of immunotherapy for lung cancer--present and future Nihon Geka Gakkai Zasshi 92(9): 1217-1220
Mathé, G.; Halle-Pannenko, O.; Bourut, C. 1973: BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy National Cancer Institute Monograph 39(8): 107-113
Senna, G.E.; Makatsori, M.; Schiappoli, M.; Dama, A.R. 2011: Subcutaneous allergen specific immunotherapy: best clinical practice as cornerstone for future development European Annals of Allergy and Clinical Immunology 43(5): 135-140
Selimov, M.A.; Pasteur, L. 1986: Past, present and future of the specific prophylaxis of hydrophobia (on the centenary of the 1st Pasteur antirabies inoculation) Voprosy Virusologii 31(3): 370-374
Rogala, B.; Glück, J. 1999: Allergen-specific IgE in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy Journal of Investigational Allergology and Clinical Immunology 9(3): 183-189
Rogala, B.; Jarzab, J.; Rymarczyk, B.; Tłuczykont, B. 2004: Allergen specific-IgG4 in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy Wiadomosci Lekarskie 57(3-4): 123-130
Chiu, S.Y. 1974: Immune response during hyperimmunization. (VI) Variation index of specific precipitins formed with different adjuvants Journal of the Formosan Medical Association 73(2): 59-67
Schirrmacher, V.; von Hoegen, P.; Heicappell, R. 1989: Virus modified tumor cell vaccines for active specific immunotherapy of micrometastases: expansion and activation of tumor-specific T cells Progress in Clinical and Biological Research 288: 391-399
de Jong, E.C.; Kapsenberg, M.L. 2006: Future perspectives of novel immunomodulating substances in immunotherapy Arbeiten aus dem Paul-Ehrlich-Institut zu Frankfurt A. M2006(95): 207
Casillas Miranda, R.; Boudet, R.V.; Vanella, L.M. 1990: Alternatives to classic immunotherapy and future possibilities Revista Alergia Mexico 37(3): 101-104
Passalacqua, G.; Lombardi, C.; Troise, C.; Canonica, G.W. 2009: Sublingual immunotherapy: certainties, unmet needs and future directions European Annals of Allergy and Clinical Immunology 41(6): 163-170
Sugie, T. 2012: Today and future perspectives in breast cancer immunotherapy Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 7): 715-719
Romański, B. 1984: Specific immunotherapy of atopic diseases Polski Tygodnik Lekarski 39(31): 1021-1026
Cheung, N.K.; Medof, M.E.; Munn, D. 1988: Immunotherapy with GD2 specific monoclonal antibodies Progress in Clinical and Biological Research 271: 619-632
Musarra, A.; Bilò, M.B.; Bonini, S.; Canonica, G.W.; Senna, G.E. 2013: Consensus on allergen specific immunotherapy European Annals of Allergy and Clinical Immunology 45(Suppl 3): 1-49
Breborowicz, A. 2003: Practical aspects of specific immunotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 14(84): 692-694
Li, P.S. 1993: The future application of adoptive immunotherapy in treatment of lung cancer Zhonghua Nei Ke Za Zhi 32(9): 579-580
Dirlewanger, M.; Hauschild, M.; Phan-Hug, F.; Schwitzgebel, Vérie.M. 2011: Current and future care for diabetes in children: from insulin to immunotherapy Revue Medicale Suisse 7(283): 430-436
Varricchio, A. 1986: Pollen monitoring, allergy and specific immunotherapy La Clinica Terapeutica 118(1): 3-8